Patents by Inventor Matthias Karrasch

Matthias Karrasch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9827196
    Abstract: The present invention relates to the use of pharmaceutical preparations comprising paclitaxel for administration to a human patient in need thereof.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: November 28, 2017
    Assignee: SynCore Biotechnology Co., Ltd.
    Inventors: Axel Mescheder, Matthias Karrasch
  • Publication number: 20160081929
    Abstract: The present invention relates to the use of pharmaceutical preparations comprising paclitaxel for administration to a human patient in need thereof.
    Type: Application
    Filed: December 4, 2015
    Publication date: March 24, 2016
    Inventors: Axel Mescheder, Matthias Karrasch
  • Patent number: 9233094
    Abstract: The present invention relates to the use of pharmaceutical preparations comprising paclitaxel for administration to a human patient in need thereof.
    Type: Grant
    Filed: May 4, 2006
    Date of Patent: January 12, 2016
    Assignee: Medigene AG
    Inventors: Axel Mescheder, Matthias Karrasch
  • Publication number: 20090317456
    Abstract: The present invention relates to a combination of at least one oncolytic virus and at least one antiangiogenic agent and to the use of this combination in tumor therapy.
    Type: Application
    Filed: October 15, 2007
    Publication date: December 24, 2009
    Applicant: MediGene AG
    Inventors: Matthias Karrasch, Axel Mescheder
  • Publication number: 20090047337
    Abstract: The present invention relates to the use of pharmaceutical preparations comprising paclitaxel for administration to a human patient in need thereof.
    Type: Application
    Filed: May 4, 2006
    Publication date: February 19, 2009
    Inventors: Axel Mescheder, Matthias Karrasch